期刊文献+

骨肉瘤继发性化疗耐药的分子机制 被引量:4

暂未订购
导出
摘要 骨肉瘤(osteosarcoma,OS)好发于15—25岁的青少年,并以男性患者居多,其发病率在儿童和青少年恶性肿瘤中居首位。OS好发于长骨干骺端、股骨远端和胫骨近端,具有很强的侵蚀性,多向肺部转移。OS主要是梭形细胞的恶性增殖,也存在软骨母细胞和成纤维细胞等亚型,只要在骨组织内被发现这些肉瘤细胞即可确诊OS。OS患者的主要临床症状是疼痛和软组织肿胀,并且高达20%~25%的患者发现有肺部转移灶,给予OS患者及时有效的治疗对缓解病情的发展具有重要的意义。OS患者仅行手术切除的存活率不足20%,但与化疗联用后,局部病变OS患者存活率猛增至70%,这说明化疗的有效性和重要性。
出处 《广东医学》 CAS 北大核心 2016年第1期140-142,共3页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:81302346) 湖北省宜昌市科技研究基金资助项目(编号:A12301-06) 湖北省宜昌市中心人民医院基金资助项目(编号:KFJ2011009)
  • 相关文献

参考文献41

  • 1Chou AJ, Gorlick R. Chemotherapy resistance in osteosarcoma: current challenges and future directions [ J ]. Expert Rev Antican- cer There, 2006, 6(7): 1075-1085.
  • 2Longhi A, Errani C, De Paolis M, et al. Primary bone osteosareo- ma in the pediatric age : state of the art [ J ]. Cancer Treat Rev, 2006, 32(6) : 423 -436.
  • 3Chou A J, Geller DS, Gorliek R. Therapy for osteosarcoma: where do we go from here? [J]. Paediatr Drugs, 2008, 10(5) : 315 - 327.
  • 4Eilber FR, Rosen G. Adjuvant chemotherapy for osteosareoma [J]. Semin Oncol, 1989, 16(4) : 312 -322.
  • 5Sakamoto A, Iwamoto Y. Current status and perspectives regarding the treatment of osteosarcoma: chemotherapy[ J]. Rev Recent Clin Trials, 2008, 3 (3) : 228 - 231.
  • 6He HT, Ni JD, Huang J. Molecular mechanisms of chemoresis- tance in osteosarcoma (Review) [J]. Oncol Lett, 2014, 7 (5) : 1352 - 1362.
  • 7Meric- Bernstam F, Gonzalez - Angulo AM. Targeting the mTOR signaling network for cancer therapy[ J]. J Clin Oneol, 2009, 27 ( 13 ) : 2278 - 2287.
  • 8Gazitt Y, Kolapathi V, Moncada K, et al. Targeted therapy of hu- man osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways[Jl. Int J Oneol, 2009, 34(2) : 551 -561.
  • 9Houghton PJ, Morton CL, Kolb EA, et al. Initial testing (stage 1 ) of the roTOR inhibitor rapamycin by the pediatric preclinical testing program[J]. Pediatr Blood Cancer, 2008, 50(4): 799- 805.
  • 10Wan X, Mendoza A, Khanna C, et al. Rapamycin inhibits ezrin - mediated metastatic behavior in a murine model of osteosarcoma [J]. Cancer Res, 2005, 65(5): 2406-2411.

二级参考文献120

  • 1SHIPITSIN M, POLYAK K. The cancer stem cell hypothesis in search of definiteions, markes, and relevance [ J]. Lab Invest, 2008, 88 (5) : 459 - 463.
  • 2KANG M K, HUR B I, KO M H, et al. Potential identity of multi - potential cancer stem - like subpopalation after radiation of cultured brain glioma[J]. BMC Neurosei, 2008, 9(15): 1 471 -2 202.
  • 3BONNET D, DICK J E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hernatopoi etic cell[J]. Nat Med, 1997, 3(7) : 730 -737.
  • 4BLAIR A, HOGGE D E, AILLES L E, et al. Lack of expression of Thy - 1 ( CD90 ) on actue myeloid leukemia cells with long - term pro- liferative ability in vitro and in vivo[ J]. Blood, 1997, 89(9): 3 104-3 112.
  • 5GUZMAN M L, JORDAN C T. Considerations for targeting malignant stem cells in leukemia[ J ]. Cancer Control, 2004, 11 (2) : 97 - 104.
  • 6HAUSWIRTH A W, FLORIAN S, PRINTZ D, et al. Expression of the target receptor CD33 in CD34^+/CD38^-/CD123^+ AML stem ceils [ J]. Eur J Clin Invest, 2007, 37 ( 1 ) : 73 - 82.
  • 7AI HAJJ M, WICHA M S, BEN1TO HERNANDEZ A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci USA, 2003, 100(7) : 3 547 -3 549.
  • 8ZUCCHI I, SANZONE S, ASTIGIANO S, et al. The properties of a mammary gland cancer stem cell[ J ]. Proc Natl Acad Sci USA, 2007, 104(25) : 10 476 - 10 481.
  • 9SINGH S K, HAWKINS C, CLARKE I D, et al. Identification of human brain tumour initiating ceils [ J ]. Nature, 2004, 432 (7 015) : 396 -401.
  • 10DALERBA P, DYLLA S J, PARK I K, et al. Phenotypic characterization of human colorectal cancer stem cells [ J ]. Proc Natl Acad Sci USA, 2007, 104(24) : 10 158 -10 163.

共引文献8

同被引文献34

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部